E. Schrinner
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Antibiotic Resistance in Bacteria 18
-
- Antibiotic Use and Resistance 3
E. Schrinner
34 papers receiving 484 citations
Peers
Comparison fields: 5 of 73
- Molecular Medicine 275
- Pharmacology 361
- Clinical Biochemistry 58
- Microbiology 48
- Infectious Diseases 127
Countries citing papers authored by E. Schrinner
This map shows the geographic impact of E. Schrinner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Schrinner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Schrinner more than expected).
Fields of papers citing papers by E. Schrinner
This network shows the impact of papers produced by E. Schrinner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Schrinner. The network helps show where E. Schrinner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E. Schrinner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pseudomonas aeruginosa infection in embryonated hen's eggs. An alternative in vivo model for the screening of antibacterial substances. | 1997 | 4 |
| 2 | [The Candida infected hen's egg. An alternative test system for systemic anticandida activity]. | 1995 | 12 |
| 3 | 1992 | 15 | |
| 4 | 1992 | 25 | |
| 5 | 1992 | 4 | |
| 6 | 1992 | 3 | |
| 7 | 1992 | 12 | |
| 8 | 1992 | 2 | |
| 9 | 1990 | 5 | |
| 10 | 1990 | 5 | |
| 11 | Synergistic antibacterial activity of cefotaxime and the penem HRE 664 in an improved in vitro model simulating serum and tissue pharmacokinetics. | 1989 | 1 |
| 12 | Surface structures of microorganisms and their interaction with the mammalian host : proceedings of the Eighteenth Workshop Conference Hoechst, Schloss Ringberg, October 20-23, 1987 | 1988 | 1 |
| 13 | 1988 | 26 | |
| 14 | 1988 | 33 | |
| 15 | 1987 | 4 | |
| 16 | 1986 | 7 | |
| 17 | 1984 | 21 | |
| 18 | 1984 | 21 | |
| 19 | [Microbiological laboratory studies with ciclopiroxolamine (author's transl)]. | 1981 | 12 |
| 20 | 1980 | 43 |
About E. Schrinner
E. Schrinner is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Infectious Diseases and Clinical Biochemistry, having authored 36 papers that have together received 576 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (22 papers), Antibiotic Resistance in Bacteria (18 papers), Phenothiazines and Benzothiazines Synthesis and Activities (7 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Drug Transport and Resistance Mechanisms (3 papers), Antibiotic Use and Resistance (3 papers), Bacterial Identification and Susceptibility Testing (3 papers) and HIV/AIDS drug development and treatment (3 papers). The work is most often cited by research in Molecular Medicine (275 citations), Pharmacology (361 citations), Clinical Biochemistry (58 citations), Microbiology (48 citations) and Infectious Diseases (127 citations). E. Schrinner has collaborated with scholars based in Germany and Croatia. Frequent co-authors include M. Limbert, Gerhard Seibert, N. Klesel, Irvin Winkler, K. Seeger, A. Markus, J. BLUMBACH, Klaus Fleischmann, Gerhard Dickneite and C Meichsner. Their work appears in journals such as The Journal of Antibiotics, Infection, Journal of Antimicrobial Chemotherapy, AIDS and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.